Smallpox and Monkeypox vaccine
Script error: No such module "Draft topics".
Script error: No such module "AfC topic".
| Vaccine description | |
|---|---|
| Target disease | Smallpox and Monkeypox |
| Type | live non-replicating |
| Clinical data | |
| Trade names | Jynneos |
| AHFS/Drugs.com | Professional Drug Facts |
| Routes of administration | Subcutaneous injection |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}} |
The Smallpox and Monkeypox Vaccine sold under the trade name Jynneos [1] is a combination of 2 vaccines apporved by the US FDA to prevent Smallpox and Monkeypox. It was approved in 2019 It is a live vaccine but cannot replicate It is in the Strategic National Stockpile (SNS), Its approved for those with a high risk of either smallpox or monkeypox infection It does not contain the viruses that cause smallpox or monkeypox. It is made from a vaccinia virus, a virus that is closely related to, but less harmful than either the variola or monkeypox viruses and can protect against both of these diseases. Jynneos contains a modified form of the vaccinia virus called Modified Vaccinia Ankara, which does not cause disease in humans and is non-replicating, meaning it cannot reproduce in human cells. This vaccine provides better protection against monkeypox then older smallpox vaccines
References[edit]
- ↑ Commissioner, Office of the (24 March 2020). "FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox". FDA. Retrieved 21 May 2022.
References[edit]
This article "Smallpox and Monkeypox vaccine" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Smallpox and Monkeypox vaccine. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
